Adam Cien, DO
Orthopaedic Surgery · South Bend, INNPI 1104183607
Payments from drug & device makers
Across 609 payments — averaging $236.02 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Stryker$138K
- Smith+Nephew$4K
- Next Science LLC$606
- Avanos Medical$304
- Pacira Therapeutics, Inc.$233
- Orthofix Medical, Inc.$203
- plus $1K from 16 others
What the payments were for
- Consulting fees$104,97573%
- Travel & lodging$16,97612%
- Food & beverage$21,78815%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Stryker | 545 | $137,845 |
| Smith+Nephew | 18 | $3,503 |
| Next Science LLC | 3 | $606 |
| Avanos Medical | 2 | $304 |
| Pacira Therapeutics, Inc. | 10 | $233 |
| Orthofix Medical, Inc. | 7 | $203 |
| Johnson & Johnson(2 entities) | 3 | $198 |
| Linkbio Corp | 1 | $186 |
| Pacira Pharmaceuticals Incorporated | 2 | $155 |
| Medical Device Business Services, Inc. | 3 | $111 |
| Zimmer Biomet | 1 | $108 |
| Heraeus Medical, LLC. | 1 | $78 |
| Vertex | 3 | $53 |
| KCI USA, Inc. | 2 | $26 |
| Nevro Corp. | 1 | $21 |
| Medacta USA, Inc. | 1 | $20 |
| SPR Therapeutics, Inc | 1 | $20 |
| Solventum Corporation | 1 | $17 |
| Merck | 1 | $14 |
| Heron Therapeutics, Inc. | 1 | $14 |
| Vericel Corporation | 1 | $13 |
| Endo Pharmaceuticals Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- MAKO$39,886
- AEQUALIS$7,763
- GMRS$7,763
- TRIDENT$7,500
- XPRESS ENT DILATION SYSTEM$4,125
- Journey II$3,715
- T2$3,692
- ADAPT$3,283
- NA$2,875
- REDAPT$2,787
- EZOUT$2,775
- STRYKER NAV3$2,450
- Legion Revision$2,212
- REAL INTELLIGENCE$2,035
- Tandem$2,035
- RESTORATION$1,744
- Legion$928
- STRYKER NAV3I$918
- VARIAX$839
- TRIATHLON$769
How this compares
$143,739 in reported general payments places this provider in the 90th percentile of 400 orthopaedic surgery providers in Indiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Celecoxib | 106 | $3,180 |
| Tranexamic Acid | 53 | $1,155 |
| Meloxicam | 465 | $949 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 85 | $601 |
| Methylprednisolone | 77 | $484 |
| Ondansetron Hcl | 75 | $457 |
| Mupirocin | 69 | $394 |
| Cyclobenzaprine Hcl | 16 | $252 |
| Amoxicillin | 167 | $199 |
| Chlorhexidine Gluconate | 67 | $176 |
| Tramadol Hcl | 77 | $164 |
| Diclofenac Sodium | 15 | $144 |
| Cephalexin | 11 | $132 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 12 | $103 |
| Clindamycin Hcl | 41 | $55 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic surgery in South Bend
- Jeffrey YerglerSouth Bend$932K
- Maxwell WinklerSouth Bend$37K
- Frank KolisekGreenwood$7.6M
- David FisherIndianapolis$5.9M
- Michael BerendIndianapolis$4.1M
- John WilliamsFort Wayne$2.7M
- Alan McGeeFort Wayne$2.3M
- Sanford KunkelIndianapolis$1.9M
- Hill HastingsIndianapolis$1.6M
- Mark KlaassenElkhart$1.4M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.